nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibuprofen—CXCL8—pancreatic cancer	0.189	0.505	CbGaD
Ibuprofen—PPARG—pancreatic cancer	0.13	0.349	CbGaD
Ibuprofen—BCL2—Docetaxel—pancreatic cancer	0.087	0.224	CbGbCtD
Ibuprofen—PTGS2—pancreatic cancer	0.0551	0.147	CbGaD
Ibuprofen—SLCO2B1—Erlotinib—pancreatic cancer	0.0303	0.0783	CbGbCtD
Ibuprofen—UGT1A9—Irinotecan—pancreatic cancer	0.025	0.0646	CbGbCtD
Ibuprofen—UGT2B7—Epirubicin—pancreatic cancer	0.0243	0.0628	CbGbCtD
Ibuprofen—UGT1A1—Erlotinib—pancreatic cancer	0.0227	0.0585	CbGbCtD
Ibuprofen—UGT1A1—Irinotecan—pancreatic cancer	0.0205	0.0528	CbGbCtD
Ibuprofen—ABCC4—Fluorouracil—pancreatic cancer	0.0201	0.0518	CbGbCtD
Ibuprofen—ABCC1—Epirubicin—pancreatic cancer	0.0173	0.0446	CbGbCtD
Ibuprofen—ABCC1—Irinotecan—pancreatic cancer	0.0168	0.0434	CbGbCtD
Ibuprofen—ABCC4—Sunitinib—pancreatic cancer	0.0153	0.0394	CbGbCtD
Ibuprofen—CFTR—ventral pancreatic duct—pancreatic cancer	0.0132	0.366	CbGeAlD
Ibuprofen—ABCC1—Docetaxel—pancreatic cancer	0.0123	0.0318	CbGbCtD
Ibuprofen—ABCC1—Doxorubicin—pancreatic cancer	0.00919	0.0237	CbGbCtD
Ibuprofen—ALB—Erlotinib—pancreatic cancer	0.00859	0.0222	CbGbCtD
Ibuprofen—CYP2C8—Tamoxifen—pancreatic cancer	0.00781	0.0202	CbGbCtD
Ibuprofen—ALB—Irinotecan—pancreatic cancer	0.00776	0.02	CbGbCtD
Ibuprofen—ALB—Fluorouracil—pancreatic cancer	0.00744	0.0192	CbGbCtD
Ibuprofen—CYP2C8—Erlotinib—pancreatic cancer	0.00664	0.0171	CbGbCtD
Ibuprofen—CYP2C19—Tamoxifen—pancreatic cancer	0.00655	0.0169	CbGbCtD
Ibuprofen—CYP2C8—Fluorouracil—pancreatic cancer	0.00575	0.0149	CbGbCtD
Ibuprofen—CYP2C9—Tamoxifen—pancreatic cancer	0.00545	0.0141	CbGbCtD
Ibuprofen—ABCB1—Tamoxifen—pancreatic cancer	0.00528	0.0136	CbGbCtD
Ibuprofen—ABCB1—Gemcitabine—pancreatic cancer	0.00455	0.0118	CbGbCtD
Ibuprofen—ABCB1—Erlotinib—pancreatic cancer	0.00449	0.0116	CbGbCtD
Ibuprofen—ABCB1—Irinotecan—pancreatic cancer	0.00406	0.0105	CbGbCtD
Ibuprofen—CYP2C9—Fluorouracil—pancreatic cancer	0.00401	0.0104	CbGbCtD
Ibuprofen—ABCB1—Docetaxel—pancreatic cancer	0.00297	0.00768	CbGbCtD
Ibuprofen—ABCB1—Sunitinib—pancreatic cancer	0.00296	0.00764	CbGbCtD
Ibuprofen—ABCB1—Doxorubicin—pancreatic cancer	0.00222	0.00572	CbGbCtD
Ibuprofen—CFTR—gall bladder—pancreatic cancer	0.00192	0.0531	CbGeAlD
Ibuprofen—FABP2—digestive system—pancreatic cancer	0.00166	0.0458	CbGeAlD
Ibuprofen—PPARG—Topotecan—Irinotecan—pancreatic cancer	0.00157	1	CbGdCrCtD
Ibuprofen—CFTR—islet of Langerhans—pancreatic cancer	0.00126	0.0348	CbGeAlD
Ibuprofen—PLAT—islet of Langerhans—pancreatic cancer	0.00124	0.0344	CbGeAlD
Ibuprofen—THBD—pancreas—pancreatic cancer	0.00124	0.0343	CbGeAlD
Ibuprofen—CXCL8—islet of Langerhans—pancreatic cancer	0.00115	0.0318	CbGeAlD
Ibuprofen—THBD—digestive system—pancreatic cancer	0.00106	0.0293	CbGeAlD
Ibuprofen—UGT1A3—digestive system—pancreatic cancer	0.00102	0.0283	CbGeAlD
Ibuprofen—CFTR—pancreas—pancreatic cancer	0.000884	0.0245	CbGeAlD
Ibuprofen—PLAT—pancreas—pancreatic cancer	0.000873	0.0242	CbGeAlD
Ibuprofen—ALB—gall bladder—pancreatic cancer	0.000854	0.0236	CbGeAlD
Ibuprofen—CXCL8—pancreas—pancreatic cancer	0.000809	0.0224	CbGeAlD
Ibuprofen—CFTR—digestive system—pancreatic cancer	0.000755	0.0209	CbGeAlD
Ibuprofen—BCL2—digestive system—pancreatic cancer	0.000746	0.0206	CbGeAlD
Ibuprofen—UGT1A9—digestive system—pancreatic cancer	0.000729	0.0202	CbGeAlD
Ibuprofen—PPARG—islet of Langerhans—pancreatic cancer	0.000597	0.0165	CbGeAlD
Ibuprofen—UGT2B7—digestive system—pancreatic cancer	0.000587	0.0162	CbGeAlD
Ibuprofen—SLC22A11—digestive system—pancreatic cancer	0.000572	0.0158	CbGeAlD
Ibuprofen—UGT1A1—digestive system—pancreatic cancer	0.000499	0.0138	CbGeAlD
Ibuprofen—PTGS2—gall bladder—pancreatic cancer	0.000465	0.0129	CbGeAlD
Ibuprofen—PPARG—pancreas—pancreatic cancer	0.00042	0.0116	CbGeAlD
Ibuprofen—ABCC4—pancreas—pancreatic cancer	0.000381	0.0105	CbGeAlD
Ibuprofen—SLCO2B1—digestive system—pancreatic cancer	0.000367	0.0102	CbGeAlD
Ibuprofen—PPARG—digestive system—pancreatic cancer	0.000358	0.00992	CbGeAlD
Ibuprofen—SLCO1A2—digestive system—pancreatic cancer	0.000338	0.00936	CbGeAlD
Ibuprofen—ABCC4—digestive system—pancreatic cancer	0.000325	0.009	CbGeAlD
Ibuprofen—PTGS2—islet of Langerhans—pancreatic cancer	0.000305	0.00844	CbGeAlD
Ibuprofen—Carprofen—PTGS2—pancreatic cancer	0.000285	0.335	CrCbGaD
Ibuprofen—CYP2C19—digestive system—pancreatic cancer	0.000271	0.00749	CbGeAlD
Ibuprofen—PTGS2—pancreas—pancreatic cancer	0.000214	0.00593	CbGeAlD
Ibuprofen—CYP2C9—digestive system—pancreatic cancer	0.00021	0.00581	CbGeAlD
Ibuprofen—PTGS1—digestive system—pancreatic cancer	0.000192	0.0053	CbGeAlD
Ibuprofen—ABCB1—islet of Langerhans—pancreatic cancer	0.000189	0.00522	CbGeAlD
Ibuprofen—PTGS2—digestive system—pancreatic cancer	0.000183	0.00507	CbGeAlD
Ibuprofen—Suprofen—PTGS2—pancreatic cancer	0.000176	0.207	CrCbGaD
Ibuprofen—Fenoprofen—PTGS2—pancreatic cancer	0.000152	0.178	CrCbGaD
Ibuprofen—Naproxen—PTGS2—pancreatic cancer	0.000138	0.163	CrCbGaD
Ibuprofen—ABCB1—pancreas—pancreatic cancer	0.000133	0.00367	CbGeAlD
Ibuprofen—ABCB1—digestive system—pancreatic cancer	0.000113	0.00313	CbGeAlD
Ibuprofen—Flurbiprofen—PTGS2—pancreatic cancer	9.9e-05	0.116	CrCbGaD
Ibuprofen—Neuropathy peripheral—Epirubicin—pancreatic cancer	4.45e-05	0.000364	CcSEcCtD
Ibuprofen—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	4.45e-05	0.000364	CcSEcCtD
Ibuprofen—Jaundice—Epirubicin—pancreatic cancer	4.42e-05	0.000362	CcSEcCtD
Ibuprofen—Stomatitis—Epirubicin—pancreatic cancer	4.42e-05	0.000362	CcSEcCtD
Ibuprofen—Urinary tract infection—Epirubicin—pancreatic cancer	4.41e-05	0.000361	CcSEcCtD
Ibuprofen—Conjunctivitis—Epirubicin—pancreatic cancer	4.41e-05	0.000361	CcSEcCtD
Ibuprofen—Dysuria—Doxorubicin—pancreatic cancer	4.4e-05	0.000361	CcSEcCtD
Ibuprofen—Neutropenia—Doxorubicin—pancreatic cancer	4.4e-05	0.000361	CcSEcCtD
Ibuprofen—Hypersensitivity—Fluorouracil—pancreatic cancer	4.38e-05	0.000359	CcSEcCtD
Ibuprofen—Dry mouth—Docetaxel—pancreatic cancer	4.38e-05	0.000358	CcSEcCtD
Ibuprofen—Sweating—Epirubicin—pancreatic cancer	4.35e-05	0.000356	CcSEcCtD
Ibuprofen—Pollakiuria—Doxorubicin—pancreatic cancer	4.35e-05	0.000356	CcSEcCtD
Ibuprofen—Asthenia—Gemcitabine—pancreatic cancer	4.34e-05	0.000355	CcSEcCtD
Ibuprofen—Haematuria—Epirubicin—pancreatic cancer	4.33e-05	0.000354	CcSEcCtD
Ibuprofen—Confusional state—Docetaxel—pancreatic cancer	4.33e-05	0.000354	CcSEcCtD
Ibuprofen—Photosensitivity reaction—Doxorubicin—pancreatic cancer	4.3e-05	0.000352	CcSEcCtD
Ibuprofen—Hepatobiliary disease—Epirubicin—pancreatic cancer	4.29e-05	0.000351	CcSEcCtD
Ibuprofen—Oedema—Docetaxel—pancreatic cancer	4.29e-05	0.000351	CcSEcCtD
Ibuprofen—Anaphylactic shock—Docetaxel—pancreatic cancer	4.29e-05	0.000351	CcSEcCtD
Ibuprofen—Epistaxis—Epirubicin—pancreatic cancer	4.28e-05	0.00035	CcSEcCtD
Ibuprofen—Pruritus—Gemcitabine—pancreatic cancer	4.28e-05	0.00035	CcSEcCtD
Ibuprofen—Infection—Docetaxel—pancreatic cancer	4.26e-05	0.000349	CcSEcCtD
Ibuprofen—Weight decreased—Doxorubicin—pancreatic cancer	4.26e-05	0.000349	CcSEcCtD
Ibuprofen—Sinusitis—Epirubicin—pancreatic cancer	4.26e-05	0.000349	CcSEcCtD
Ibuprofen—Hyperglycaemia—Doxorubicin—pancreatic cancer	4.25e-05	0.000348	CcSEcCtD
Ibuprofen—Diarrhoea—Irinotecan—pancreatic cancer	4.25e-05	0.000348	CcSEcCtD
Ibuprofen—Agranulocytosis—Epirubicin—pancreatic cancer	4.24e-05	0.000347	CcSEcCtD
Ibuprofen—Pneumonia—Doxorubicin—pancreatic cancer	4.22e-05	0.000346	CcSEcCtD
Ibuprofen—Shock—Docetaxel—pancreatic cancer	4.22e-05	0.000346	CcSEcCtD
Ibuprofen—Nervous system disorder—Docetaxel—pancreatic cancer	4.21e-05	0.000345	CcSEcCtD
Ibuprofen—Pruritus—Fluorouracil—pancreatic cancer	4.21e-05	0.000344	CcSEcCtD
Ibuprofen—Thrombocytopenia—Docetaxel—pancreatic cancer	4.2e-05	0.000344	CcSEcCtD
Ibuprofen—Drowsiness—Doxorubicin—pancreatic cancer	4.2e-05	0.000344	CcSEcCtD
Ibuprofen—Tachycardia—Docetaxel—pancreatic cancer	4.19e-05	0.000343	CcSEcCtD
Ibuprofen—Skin disorder—Docetaxel—pancreatic cancer	4.17e-05	0.000341	CcSEcCtD
Ibuprofen—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	4.16e-05	0.000341	CcSEcCtD
Ibuprofen—Diarrhoea—Gemcitabine—pancreatic cancer	4.14e-05	0.000339	CcSEcCtD
Ibuprofen—Renal failure—Doxorubicin—pancreatic cancer	4.13e-05	0.000338	CcSEcCtD
Ibuprofen—Neuropathy peripheral—Doxorubicin—pancreatic cancer	4.12e-05	0.000337	CcSEcCtD
Ibuprofen—Dizziness—Irinotecan—pancreatic cancer	4.11e-05	0.000336	CcSEcCtD
Ibuprofen—Haemoglobin—Epirubicin—pancreatic cancer	4.09e-05	0.000335	CcSEcCtD
Ibuprofen—Stomatitis—Doxorubicin—pancreatic cancer	4.09e-05	0.000335	CcSEcCtD
Ibuprofen—Jaundice—Doxorubicin—pancreatic cancer	4.09e-05	0.000335	CcSEcCtD
Ibuprofen—Anorexia—Docetaxel—pancreatic cancer	4.09e-05	0.000335	CcSEcCtD
Ibuprofen—Rhinitis—Epirubicin—pancreatic cancer	4.08e-05	0.000334	CcSEcCtD
Ibuprofen—Urinary tract infection—Doxorubicin—pancreatic cancer	4.08e-05	0.000334	CcSEcCtD
Ibuprofen—Conjunctivitis—Doxorubicin—pancreatic cancer	4.08e-05	0.000334	CcSEcCtD
Ibuprofen—Haemorrhage—Epirubicin—pancreatic cancer	4.07e-05	0.000334	CcSEcCtD
Ibuprofen—Hepatitis—Epirubicin—pancreatic cancer	4.07e-05	0.000334	CcSEcCtD
Ibuprofen—Diarrhoea—Fluorouracil—pancreatic cancer	4.07e-05	0.000333	CcSEcCtD
Ibuprofen—Pharyngitis—Epirubicin—pancreatic cancer	4.04e-05	0.000331	CcSEcCtD
Ibuprofen—Sweating—Doxorubicin—pancreatic cancer	4.03e-05	0.00033	CcSEcCtD
Ibuprofen—Urinary tract disorder—Epirubicin—pancreatic cancer	4.02e-05	0.000329	CcSEcCtD
Ibuprofen—Oedema peripheral—Epirubicin—pancreatic cancer	4.01e-05	0.000329	CcSEcCtD
Ibuprofen—Hypotension—Docetaxel—pancreatic cancer	4.01e-05	0.000328	CcSEcCtD
Ibuprofen—Haematuria—Doxorubicin—pancreatic cancer	4e-05	0.000328	CcSEcCtD
Ibuprofen—Urethral disorder—Epirubicin—pancreatic cancer	3.99e-05	0.000327	CcSEcCtD
Ibuprofen—Hepatobiliary disease—Doxorubicin—pancreatic cancer	3.97e-05	0.000325	CcSEcCtD
Ibuprofen—Epistaxis—Doxorubicin—pancreatic cancer	3.96e-05	0.000324	CcSEcCtD
Ibuprofen—Vomiting—Irinotecan—pancreatic cancer	3.95e-05	0.000323	CcSEcCtD
Ibuprofen—Sinusitis—Doxorubicin—pancreatic cancer	3.94e-05	0.000323	CcSEcCtD
Ibuprofen—Dizziness—Fluorouracil—pancreatic cancer	3.93e-05	0.000322	CcSEcCtD
Ibuprofen—Visual impairment—Epirubicin—pancreatic cancer	3.93e-05	0.000321	CcSEcCtD
Ibuprofen—Agranulocytosis—Doxorubicin—pancreatic cancer	3.92e-05	0.000321	CcSEcCtD
Ibuprofen—Rash—Irinotecan—pancreatic cancer	3.91e-05	0.00032	CcSEcCtD
Ibuprofen—Dermatitis—Irinotecan—pancreatic cancer	3.91e-05	0.00032	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	3.91e-05	0.00032	CcSEcCtD
Ibuprofen—Headache—Irinotecan—pancreatic cancer	3.89e-05	0.000318	CcSEcCtD
Ibuprofen—Insomnia—Docetaxel—pancreatic cancer	3.88e-05	0.000318	CcSEcCtD
Ibuprofen—Paraesthesia—Docetaxel—pancreatic cancer	3.85e-05	0.000315	CcSEcCtD
Ibuprofen—Erythema multiforme—Epirubicin—pancreatic cancer	3.85e-05	0.000315	CcSEcCtD
Ibuprofen—Vomiting—Gemcitabine—pancreatic cancer	3.84e-05	0.000315	CcSEcCtD
Ibuprofen—Dyspnoea—Docetaxel—pancreatic cancer	3.83e-05	0.000313	CcSEcCtD
Ibuprofen—Somnolence—Docetaxel—pancreatic cancer	3.81e-05	0.000312	CcSEcCtD
Ibuprofen—Rash—Gemcitabine—pancreatic cancer	3.81e-05	0.000312	CcSEcCtD
Ibuprofen—Dermatitis—Gemcitabine—pancreatic cancer	3.81e-05	0.000312	CcSEcCtD
Ibuprofen—Tinnitus—Epirubicin—pancreatic cancer	3.8e-05	0.000311	CcSEcCtD
Ibuprofen—Haemoglobin—Doxorubicin—pancreatic cancer	3.79e-05	0.00031	CcSEcCtD
Ibuprofen—Headache—Gemcitabine—pancreatic cancer	3.79e-05	0.00031	CcSEcCtD
Ibuprofen—Vomiting—Fluorouracil—pancreatic cancer	3.78e-05	0.00031	CcSEcCtD
Ibuprofen—Rhinitis—Doxorubicin—pancreatic cancer	3.78e-05	0.000309	CcSEcCtD
Ibuprofen—Dyspepsia—Docetaxel—pancreatic cancer	3.78e-05	0.000309	CcSEcCtD
Ibuprofen—Haemorrhage—Doxorubicin—pancreatic cancer	3.77e-05	0.000309	CcSEcCtD
Ibuprofen—Hepatitis—Doxorubicin—pancreatic cancer	3.77e-05	0.000309	CcSEcCtD
Ibuprofen—Rash—Fluorouracil—pancreatic cancer	3.75e-05	0.000307	CcSEcCtD
Ibuprofen—Dermatitis—Fluorouracil—pancreatic cancer	3.75e-05	0.000307	CcSEcCtD
Ibuprofen—Pharyngitis—Doxorubicin—pancreatic cancer	3.74e-05	0.000306	CcSEcCtD
Ibuprofen—Decreased appetite—Docetaxel—pancreatic cancer	3.73e-05	0.000305	CcSEcCtD
Ibuprofen—Headache—Fluorouracil—pancreatic cancer	3.72e-05	0.000305	CcSEcCtD
Ibuprofen—Urinary tract disorder—Doxorubicin—pancreatic cancer	3.72e-05	0.000305	CcSEcCtD
Ibuprofen—Oedema peripheral—Doxorubicin—pancreatic cancer	3.71e-05	0.000304	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Docetaxel—pancreatic cancer	3.7e-05	0.000303	CcSEcCtD
Ibuprofen—Fatigue—Docetaxel—pancreatic cancer	3.7e-05	0.000303	CcSEcCtD
Ibuprofen—Urethral disorder—Doxorubicin—pancreatic cancer	3.7e-05	0.000303	CcSEcCtD
Ibuprofen—Nausea—Irinotecan—pancreatic cancer	3.69e-05	0.000302	CcSEcCtD
Ibuprofen—Immune system disorder—Epirubicin—pancreatic cancer	3.68e-05	0.000301	CcSEcCtD
Ibuprofen—Mediastinal disorder—Epirubicin—pancreatic cancer	3.67e-05	0.000301	CcSEcCtD
Ibuprofen—Constipation—Docetaxel—pancreatic cancer	3.67e-05	0.0003	CcSEcCtD
Ibuprofen—Chills—Epirubicin—pancreatic cancer	3.66e-05	0.000299	CcSEcCtD
Ibuprofen—Arrhythmia—Epirubicin—pancreatic cancer	3.64e-05	0.000298	CcSEcCtD
Ibuprofen—Visual impairment—Doxorubicin—pancreatic cancer	3.63e-05	0.000297	CcSEcCtD
Ibuprofen—Alopecia—Epirubicin—pancreatic cancer	3.6e-05	0.000295	CcSEcCtD
Ibuprofen—Nausea—Gemcitabine—pancreatic cancer	3.59e-05	0.000294	CcSEcCtD
Ibuprofen—Mental disorder—Epirubicin—pancreatic cancer	3.57e-05	0.000292	CcSEcCtD
Ibuprofen—Erythema multiforme—Doxorubicin—pancreatic cancer	3.56e-05	0.000292	CcSEcCtD
Ibuprofen—Erythema—Epirubicin—pancreatic cancer	3.55e-05	0.00029	CcSEcCtD
Ibuprofen—Malnutrition—Epirubicin—pancreatic cancer	3.55e-05	0.00029	CcSEcCtD
Ibuprofen—Feeling abnormal—Docetaxel—pancreatic cancer	3.54e-05	0.00029	CcSEcCtD
Ibuprofen—Nausea—Fluorouracil—pancreatic cancer	3.53e-05	0.000289	CcSEcCtD
Ibuprofen—Tinnitus—Doxorubicin—pancreatic cancer	3.51e-05	0.000288	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Docetaxel—pancreatic cancer	3.51e-05	0.000287	CcSEcCtD
Ibuprofen—Flatulence—Epirubicin—pancreatic cancer	3.49e-05	0.000286	CcSEcCtD
Ibuprofen—Tension—Epirubicin—pancreatic cancer	3.48e-05	0.000285	CcSEcCtD
Ibuprofen—Dysgeusia—Epirubicin—pancreatic cancer	3.47e-05	0.000284	CcSEcCtD
Ibuprofen—Nervousness—Epirubicin—pancreatic cancer	3.44e-05	0.000282	CcSEcCtD
Ibuprofen—Muscle spasms—Epirubicin—pancreatic cancer	3.41e-05	0.000279	CcSEcCtD
Ibuprofen—Immune system disorder—Doxorubicin—pancreatic cancer	3.4e-05	0.000279	CcSEcCtD
Ibuprofen—Mediastinal disorder—Doxorubicin—pancreatic cancer	3.4e-05	0.000278	CcSEcCtD
Ibuprofen—Abdominal pain—Docetaxel—pancreatic cancer	3.39e-05	0.000278	CcSEcCtD
Ibuprofen—Chills—Doxorubicin—pancreatic cancer	3.38e-05	0.000277	CcSEcCtD
Ibuprofen—Arrhythmia—Doxorubicin—pancreatic cancer	3.37e-05	0.000276	CcSEcCtD
Ibuprofen—Vision blurred—Epirubicin—pancreatic cancer	3.34e-05	0.000274	CcSEcCtD
Ibuprofen—Alopecia—Doxorubicin—pancreatic cancer	3.33e-05	0.000273	CcSEcCtD
Ibuprofen—Mental disorder—Doxorubicin—pancreatic cancer	3.3e-05	0.00027	CcSEcCtD
Ibuprofen—Ill-defined disorder—Epirubicin—pancreatic cancer	3.29e-05	0.000269	CcSEcCtD
Ibuprofen—Malnutrition—Doxorubicin—pancreatic cancer	3.28e-05	0.000269	CcSEcCtD
Ibuprofen—Erythema—Doxorubicin—pancreatic cancer	3.28e-05	0.000269	CcSEcCtD
Ibuprofen—Anaemia—Epirubicin—pancreatic cancer	3.28e-05	0.000268	CcSEcCtD
Ibuprofen—Agitation—Epirubicin—pancreatic cancer	3.26e-05	0.000267	CcSEcCtD
Ibuprofen—Flatulence—Doxorubicin—pancreatic cancer	3.23e-05	0.000265	CcSEcCtD
Ibuprofen—Tension—Doxorubicin—pancreatic cancer	3.22e-05	0.000264	CcSEcCtD
Ibuprofen—Dysgeusia—Doxorubicin—pancreatic cancer	3.21e-05	0.000263	CcSEcCtD
Ibuprofen—Malaise—Epirubicin—pancreatic cancer	3.2e-05	0.000262	CcSEcCtD
Ibuprofen—Nervousness—Doxorubicin—pancreatic cancer	3.19e-05	0.000261	CcSEcCtD
Ibuprofen—Vertigo—Epirubicin—pancreatic cancer	3.19e-05	0.000261	CcSEcCtD
Ibuprofen—Syncope—Epirubicin—pancreatic cancer	3.18e-05	0.00026	CcSEcCtD
Ibuprofen—Leukopenia—Epirubicin—pancreatic cancer	3.17e-05	0.00026	CcSEcCtD
Ibuprofen—Hypersensitivity—Docetaxel—pancreatic cancer	3.16e-05	0.000259	CcSEcCtD
Ibuprofen—Muscle spasms—Doxorubicin—pancreatic cancer	3.15e-05	0.000258	CcSEcCtD
Ibuprofen—Palpitations—Epirubicin—pancreatic cancer	3.13e-05	0.000257	CcSEcCtD
Ibuprofen—Loss of consciousness—Epirubicin—pancreatic cancer	3.12e-05	0.000255	CcSEcCtD
Ibuprofen—Cough—Epirubicin—pancreatic cancer	3.09e-05	0.000253	CcSEcCtD
Ibuprofen—Vision blurred—Doxorubicin—pancreatic cancer	3.09e-05	0.000253	CcSEcCtD
Ibuprofen—Asthenia—Docetaxel—pancreatic cancer	3.08e-05	0.000252	CcSEcCtD
Ibuprofen—Convulsion—Epirubicin—pancreatic cancer	3.07e-05	0.000252	CcSEcCtD
Ibuprofen—Hypertension—Epirubicin—pancreatic cancer	3.06e-05	0.000251	CcSEcCtD
Ibuprofen—Ill-defined disorder—Doxorubicin—pancreatic cancer	3.04e-05	0.000249	CcSEcCtD
Ibuprofen—Pruritus—Docetaxel—pancreatic cancer	3.04e-05	0.000249	CcSEcCtD
Ibuprofen—Anaemia—Doxorubicin—pancreatic cancer	3.03e-05	0.000248	CcSEcCtD
Ibuprofen—Arthralgia—Epirubicin—pancreatic cancer	3.02e-05	0.000247	CcSEcCtD
Ibuprofen—Myalgia—Epirubicin—pancreatic cancer	3.02e-05	0.000247	CcSEcCtD
Ibuprofen—Agitation—Doxorubicin—pancreatic cancer	3.02e-05	0.000247	CcSEcCtD
Ibuprofen—Anxiety—Epirubicin—pancreatic cancer	3.01e-05	0.000246	CcSEcCtD
Ibuprofen—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	3e-05	0.000246	CcSEcCtD
Ibuprofen—Discomfort—Epirubicin—pancreatic cancer	2.98e-05	0.000244	CcSEcCtD
Ibuprofen—Malaise—Doxorubicin—pancreatic cancer	2.96e-05	0.000242	CcSEcCtD
Ibuprofen—Dry mouth—Epirubicin—pancreatic cancer	2.95e-05	0.000242	CcSEcCtD
Ibuprofen—Vertigo—Doxorubicin—pancreatic cancer	2.95e-05	0.000241	CcSEcCtD
Ibuprofen—Syncope—Doxorubicin—pancreatic cancer	2.94e-05	0.000241	CcSEcCtD
Ibuprofen—Leukopenia—Doxorubicin—pancreatic cancer	2.94e-05	0.00024	CcSEcCtD
Ibuprofen—Diarrhoea—Docetaxel—pancreatic cancer	2.94e-05	0.00024	CcSEcCtD
Ibuprofen—Confusional state—Epirubicin—pancreatic cancer	2.92e-05	0.000239	CcSEcCtD
Ibuprofen—Palpitations—Doxorubicin—pancreatic cancer	2.9e-05	0.000237	CcSEcCtD
Ibuprofen—Oedema—Epirubicin—pancreatic cancer	2.89e-05	0.000237	CcSEcCtD
Ibuprofen—Anaphylactic shock—Epirubicin—pancreatic cancer	2.89e-05	0.000237	CcSEcCtD
Ibuprofen—Loss of consciousness—Doxorubicin—pancreatic cancer	2.88e-05	0.000236	CcSEcCtD
Ibuprofen—Infection—Epirubicin—pancreatic cancer	2.88e-05	0.000235	CcSEcCtD
Ibuprofen—Cough—Doxorubicin—pancreatic cancer	2.86e-05	0.000234	CcSEcCtD
Ibuprofen—Shock—Epirubicin—pancreatic cancer	2.85e-05	0.000233	CcSEcCtD
Ibuprofen—Convulsion—Doxorubicin—pancreatic cancer	2.84e-05	0.000233	CcSEcCtD
Ibuprofen—Nervous system disorder—Epirubicin—pancreatic cancer	2.84e-05	0.000232	CcSEcCtD
Ibuprofen—Dizziness—Docetaxel—pancreatic cancer	2.84e-05	0.000232	CcSEcCtD
Ibuprofen—Thrombocytopenia—Epirubicin—pancreatic cancer	2.83e-05	0.000232	CcSEcCtD
Ibuprofen—Hypertension—Doxorubicin—pancreatic cancer	2.83e-05	0.000232	CcSEcCtD
Ibuprofen—Tachycardia—Epirubicin—pancreatic cancer	2.82e-05	0.000231	CcSEcCtD
Ibuprofen—Skin disorder—Epirubicin—pancreatic cancer	2.81e-05	0.00023	CcSEcCtD
Ibuprofen—Hyperhidrosis—Epirubicin—pancreatic cancer	2.8e-05	0.000229	CcSEcCtD
Ibuprofen—Arthralgia—Doxorubicin—pancreatic cancer	2.79e-05	0.000229	CcSEcCtD
Ibuprofen—Myalgia—Doxorubicin—pancreatic cancer	2.79e-05	0.000229	CcSEcCtD
Ibuprofen—Anxiety—Doxorubicin—pancreatic cancer	2.78e-05	0.000228	CcSEcCtD
Ibuprofen—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	2.77e-05	0.000227	CcSEcCtD
Ibuprofen—Discomfort—Doxorubicin—pancreatic cancer	2.76e-05	0.000226	CcSEcCtD
Ibuprofen—Anorexia—Epirubicin—pancreatic cancer	2.76e-05	0.000226	CcSEcCtD
Ibuprofen—Dry mouth—Doxorubicin—pancreatic cancer	2.73e-05	0.000224	CcSEcCtD
Ibuprofen—Vomiting—Docetaxel—pancreatic cancer	2.73e-05	0.000223	CcSEcCtD
Ibuprofen—Rash—Docetaxel—pancreatic cancer	2.71e-05	0.000222	CcSEcCtD
Ibuprofen—Hypotension—Epirubicin—pancreatic cancer	2.7e-05	0.000221	CcSEcCtD
Ibuprofen—Dermatitis—Docetaxel—pancreatic cancer	2.7e-05	0.000221	CcSEcCtD
Ibuprofen—Confusional state—Doxorubicin—pancreatic cancer	2.7e-05	0.000221	CcSEcCtD
Ibuprofen—Headache—Docetaxel—pancreatic cancer	2.69e-05	0.00022	CcSEcCtD
Ibuprofen—Oedema—Doxorubicin—pancreatic cancer	2.68e-05	0.000219	CcSEcCtD
Ibuprofen—Anaphylactic shock—Doxorubicin—pancreatic cancer	2.68e-05	0.000219	CcSEcCtD
Ibuprofen—Infection—Doxorubicin—pancreatic cancer	2.66e-05	0.000218	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	2.64e-05	0.000216	CcSEcCtD
Ibuprofen—Shock—Doxorubicin—pancreatic cancer	2.63e-05	0.000216	CcSEcCtD
Ibuprofen—Nervous system disorder—Doxorubicin—pancreatic cancer	2.63e-05	0.000215	CcSEcCtD
Ibuprofen—Thrombocytopenia—Doxorubicin—pancreatic cancer	2.62e-05	0.000215	CcSEcCtD
Ibuprofen—Insomnia—Epirubicin—pancreatic cancer	2.62e-05	0.000214	CcSEcCtD
Ibuprofen—Tachycardia—Doxorubicin—pancreatic cancer	2.61e-05	0.000214	CcSEcCtD
Ibuprofen—Skin disorder—Doxorubicin—pancreatic cancer	2.6e-05	0.000213	CcSEcCtD
Ibuprofen—Paraesthesia—Epirubicin—pancreatic cancer	2.6e-05	0.000213	CcSEcCtD
Ibuprofen—Hyperhidrosis—Doxorubicin—pancreatic cancer	2.59e-05	0.000212	CcSEcCtD
Ibuprofen—Dyspnoea—Epirubicin—pancreatic cancer	2.58e-05	0.000211	CcSEcCtD
Ibuprofen—Somnolence—Epirubicin—pancreatic cancer	2.57e-05	0.000211	CcSEcCtD
Ibuprofen—Anorexia—Doxorubicin—pancreatic cancer	2.55e-05	0.000209	CcSEcCtD
Ibuprofen—Nausea—Docetaxel—pancreatic cancer	2.55e-05	0.000209	CcSEcCtD
Ibuprofen—Dyspepsia—Epirubicin—pancreatic cancer	2.55e-05	0.000209	CcSEcCtD
Ibuprofen—Decreased appetite—Epirubicin—pancreatic cancer	2.52e-05	0.000206	CcSEcCtD
Ibuprofen—Hypotension—Doxorubicin—pancreatic cancer	2.5e-05	0.000205	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Epirubicin—pancreatic cancer	2.5e-05	0.000205	CcSEcCtD
Ibuprofen—Fatigue—Epirubicin—pancreatic cancer	2.5e-05	0.000204	CcSEcCtD
Ibuprofen—Constipation—Epirubicin—pancreatic cancer	2.48e-05	0.000203	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	2.44e-05	0.0002	CcSEcCtD
Ibuprofen—Insomnia—Doxorubicin—pancreatic cancer	2.42e-05	0.000198	CcSEcCtD
Ibuprofen—Paraesthesia—Doxorubicin—pancreatic cancer	2.4e-05	0.000197	CcSEcCtD
Ibuprofen—Dyspnoea—Doxorubicin—pancreatic cancer	2.39e-05	0.000195	CcSEcCtD
Ibuprofen—Feeling abnormal—Epirubicin—pancreatic cancer	2.39e-05	0.000195	CcSEcCtD
Ibuprofen—Somnolence—Doxorubicin—pancreatic cancer	2.38e-05	0.000195	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Epirubicin—pancreatic cancer	2.37e-05	0.000194	CcSEcCtD
Ibuprofen—Dyspepsia—Doxorubicin—pancreatic cancer	2.36e-05	0.000193	CcSEcCtD
Ibuprofen—Decreased appetite—Doxorubicin—pancreatic cancer	2.33e-05	0.000191	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	2.31e-05	0.000189	CcSEcCtD
Ibuprofen—Fatigue—Doxorubicin—pancreatic cancer	2.31e-05	0.000189	CcSEcCtD
Ibuprofen—Urticaria—Epirubicin—pancreatic cancer	2.3e-05	0.000188	CcSEcCtD
Ibuprofen—Constipation—Doxorubicin—pancreatic cancer	2.29e-05	0.000188	CcSEcCtD
Ibuprofen—Abdominal pain—Epirubicin—pancreatic cancer	2.29e-05	0.000187	CcSEcCtD
Ibuprofen—Feeling abnormal—Doxorubicin—pancreatic cancer	2.21e-05	0.000181	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Doxorubicin—pancreatic cancer	2.19e-05	0.000179	CcSEcCtD
Ibuprofen—Hypersensitivity—Epirubicin—pancreatic cancer	2.13e-05	0.000175	CcSEcCtD
Ibuprofen—Urticaria—Doxorubicin—pancreatic cancer	2.13e-05	0.000174	CcSEcCtD
Ibuprofen—Abdominal pain—Doxorubicin—pancreatic cancer	2.12e-05	0.000173	CcSEcCtD
Ibuprofen—Asthenia—Epirubicin—pancreatic cancer	2.08e-05	0.00017	CcSEcCtD
Ibuprofen—Pruritus—Epirubicin—pancreatic cancer	2.05e-05	0.000168	CcSEcCtD
Ibuprofen—Diarrhoea—Epirubicin—pancreatic cancer	1.98e-05	0.000162	CcSEcCtD
Ibuprofen—Hypersensitivity—Doxorubicin—pancreatic cancer	1.97e-05	0.000162	CcSEcCtD
Ibuprofen—Asthenia—Doxorubicin—pancreatic cancer	1.92e-05	0.000157	CcSEcCtD
Ibuprofen—Dizziness—Epirubicin—pancreatic cancer	1.91e-05	0.000157	CcSEcCtD
Ibuprofen—Pruritus—Doxorubicin—pancreatic cancer	1.89e-05	0.000155	CcSEcCtD
Ibuprofen—Vomiting—Epirubicin—pancreatic cancer	1.84e-05	0.000151	CcSEcCtD
Ibuprofen—Diarrhoea—Doxorubicin—pancreatic cancer	1.83e-05	0.00015	CcSEcCtD
Ibuprofen—Rash—Epirubicin—pancreatic cancer	1.83e-05	0.000149	CcSEcCtD
Ibuprofen—Dermatitis—Epirubicin—pancreatic cancer	1.82e-05	0.000149	CcSEcCtD
Ibuprofen—Headache—Epirubicin—pancreatic cancer	1.81e-05	0.000148	CcSEcCtD
Ibuprofen—Dizziness—Doxorubicin—pancreatic cancer	1.77e-05	0.000145	CcSEcCtD
Ibuprofen—Nausea—Epirubicin—pancreatic cancer	1.72e-05	0.000141	CcSEcCtD
Ibuprofen—Vomiting—Doxorubicin—pancreatic cancer	1.7e-05	0.000139	CcSEcCtD
Ibuprofen—Rash—Doxorubicin—pancreatic cancer	1.69e-05	0.000138	CcSEcCtD
Ibuprofen—Dermatitis—Doxorubicin—pancreatic cancer	1.69e-05	0.000138	CcSEcCtD
Ibuprofen—Headache—Doxorubicin—pancreatic cancer	1.68e-05	0.000137	CcSEcCtD
Ibuprofen—Nausea—Doxorubicin—pancreatic cancer	1.59e-05	0.00013	CcSEcCtD
Ibuprofen—PTGS2—Disease—SMAD4—pancreatic cancer	4.26e-06	5.47e-05	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—PIK3CG—pancreatic cancer	4.26e-06	5.47e-05	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—EGFR—pancreatic cancer	4.25e-06	5.46e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—APOE—pancreatic cancer	4.24e-06	5.45e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	4.24e-06	5.44e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.24e-06	5.44e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—KRAS—pancreatic cancer	4.22e-06	5.42e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.19e-06	5.38e-05	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.17e-06	5.35e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—HES1—pancreatic cancer	4.16e-06	5.34e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—GLP1R—pancreatic cancer	4.14e-06	5.31e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—SLC2A2—pancreatic cancer	4.13e-06	5.31e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.13e-06	5.3e-05	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—PPARG—pancreatic cancer	4.11e-06	5.28e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.1e-06	5.27e-05	CbGpPWpGaD
Ibuprofen—UGT2B4—Metabolism—AKT1—pancreatic cancer	4.1e-06	5.26e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—STK11—pancreatic cancer	4.07e-06	5.23e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—DPYD—pancreatic cancer	4.07e-06	5.23e-05	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—PIK3CD—pancreatic cancer	4.06e-06	5.22e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.05e-06	5.2e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—PIK3CD—pancreatic cancer	4.02e-06	5.16e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.02e-06	5.16e-05	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—KRAS—pancreatic cancer	4.02e-06	5.16e-05	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—PIK3CA—pancreatic cancer	3.97e-06	5.1e-05	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—PIK3CG—pancreatic cancer	3.97e-06	5.1e-05	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—PIK3CG—pancreatic cancer	3.97e-06	5.1e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—PIK3CB—pancreatic cancer	3.93e-06	5.05e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—PIK3CA—pancreatic cancer	3.88e-06	4.98e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	3.86e-06	4.96e-05	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—TP53—pancreatic cancer	3.84e-06	4.94e-05	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—PPARG—pancreatic cancer	3.83e-06	4.92e-05	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—PPARG—pancreatic cancer	3.83e-06	4.92e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—PIK3CG—pancreatic cancer	3.83e-06	4.92e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.82e-06	4.91e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.82e-06	4.91e-05	CbGpPWpGaD
Ibuprofen—UGT1A3—Metabolism—PTEN—pancreatic cancer	3.81e-06	4.89e-05	CbGpPWpGaD
Ibuprofen—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	3.8e-06	4.88e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—PIK3CB—pancreatic cancer	3.76e-06	4.83e-05	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—PIK3CB—pancreatic cancer	3.75e-06	4.81e-05	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—PIK3CD—pancreatic cancer	3.74e-06	4.81e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	3.74e-06	4.8e-05	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—PTGS2—pancreatic cancer	3.71e-06	4.77e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—PPARG—pancreatic cancer	3.7e-06	4.75e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.69e-06	4.74e-05	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—PIK3CA—pancreatic cancer	3.69e-06	4.74e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.68e-06	4.73e-05	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—HRAS—pancreatic cancer	3.68e-06	4.72e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—CD44—pancreatic cancer	3.67e-06	4.72e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—CD44—pancreatic cancer	3.65e-06	4.69e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—TERT—pancreatic cancer	3.64e-06	4.68e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.6e-06	4.62e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—HRAS—pancreatic cancer	3.59e-06	4.61e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—APOE—pancreatic cancer	3.59e-06	4.61e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.58e-06	4.6e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.57e-06	4.58e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.55e-06	4.55e-05	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—PIK3CB—pancreatic cancer	3.54e-06	4.55e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—GCG—pancreatic cancer	3.52e-06	4.53e-05	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—PTGS2—pancreatic cancer	3.51e-06	4.51e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—PIK3CB—pancreatic cancer	3.5e-06	4.5e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—GCG—pancreatic cancer	3.5e-06	4.5e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—TYMS—pancreatic cancer	3.5e-06	4.5e-05	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—PIK3CD—pancreatic cancer	3.49e-06	4.48e-05	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—PIK3CD—pancreatic cancer	3.49e-06	4.48e-05	CbGpPWpGaD
Ibuprofen—CXCL8—GPCR downstream signaling—AKT1—pancreatic cancer	3.49e-06	4.48e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—HIF1A—pancreatic cancer	3.48e-06	4.47e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—TSC2—pancreatic cancer	3.48e-06	4.46e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—PTGS2—pancreatic cancer	3.47e-06	4.46e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—CASP3—pancreatic cancer	3.46e-06	4.44e-05	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—HRAS—pancreatic cancer	3.41e-06	4.38e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—APOE—pancreatic cancer	3.4e-06	4.37e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.4e-06	4.36e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—PIK3CD—pancreatic cancer	3.37e-06	4.32e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—CCND1—pancreatic cancer	3.37e-06	4.32e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.36e-06	4.32e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—CTNNB1—pancreatic cancer	3.33e-06	4.28e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—STK11—pancreatic cancer	3.31e-06	4.25e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—STK11—pancreatic cancer	3.29e-06	4.23e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—CD44—pancreatic cancer	3.28e-06	4.21e-05	CbGpPWpGaD
Ibuprofen—PPARG—Gene Expression—MYC—pancreatic cancer	3.27e-06	4.2e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—MMP9—pancreatic cancer	3.27e-06	4.2e-05	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—PIK3CB—pancreatic cancer	3.26e-06	4.19e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—PTEN—pancreatic cancer	3.25e-06	4.17e-05	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—AKT1—pancreatic cancer	3.25e-06	4.17e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—PIK3CG—pancreatic cancer	3.24e-06	4.16e-05	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—PTEN—pancreatic cancer	3.24e-06	4.16e-05	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—PTGS2—pancreatic cancer	3.23e-06	4.15e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.21e-06	4.13e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—CD44—pancreatic cancer	3.2e-06	4.11e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.18e-06	4.09e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—AKT1—pancreatic cancer	3.17e-06	4.07e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—SRC—pancreatic cancer	3.15e-06	4.05e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—GCG—pancreatic cancer	3.14e-06	4.04e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—NOTCH1—pancreatic cancer	3.14e-06	4.03e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—PPARG—pancreatic cancer	3.13e-06	4.01e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.11e-06	3.99e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—CTNNB1—pancreatic cancer	3.11e-06	3.99e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.09e-06	3.97e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—GCG—pancreatic cancer	3.07e-06	3.94e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—VEGFA—pancreatic cancer	3.07e-06	3.94e-05	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—PTEN—pancreatic cancer	3.06e-06	3.93e-05	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—PIK3CB—pancreatic cancer	3.04e-06	3.91e-05	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—PIK3CB—pancreatic cancer	3.04e-06	3.91e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—EGF—pancreatic cancer	3.03e-06	3.9e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—NRAS—pancreatic cancer	3.03e-06	3.89e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—PTEN—pancreatic cancer	3.03e-06	3.89e-05	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—PTGS2—pancreatic cancer	3.02e-06	3.87e-05	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—PTGS2—pancreatic cancer	3.02e-06	3.87e-05	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—AKT1—pancreatic cancer	3.01e-06	3.87e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—SRC—pancreatic cancer	3.01e-06	3.87e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—CD44—pancreatic cancer	2.99e-06	3.84e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—STK11—pancreatic cancer	2.96e-06	3.8e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—PIK3CB—pancreatic cancer	2.93e-06	3.77e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—VEGFA—pancreatic cancer	2.93e-06	3.77e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.93e-06	3.76e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—PTGS2—pancreatic cancer	2.91e-06	3.73e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—STAT3—pancreatic cancer	2.91e-06	3.73e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.9e-06	3.73e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—NRAS—pancreatic cancer	2.9e-06	3.72e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—STK11—pancreatic cancer	2.89e-06	3.71e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—GCG—pancreatic cancer	2.87e-06	3.68e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—TYMS—pancreatic cancer	2.85e-06	3.66e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—APOE—pancreatic cancer	2.85e-06	3.66e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—PIK3CD—pancreatic cancer	2.85e-06	3.66e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—TYMS—pancreatic cancer	2.83e-06	3.64e-05	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—PTEN—pancreatic cancer	2.82e-06	3.62e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—TGFB1—pancreatic cancer	2.82e-06	3.62e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—SRC—pancreatic cancer	2.81e-06	3.61e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.78e-06	3.56e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—STAT3—pancreatic cancer	2.71e-06	3.48e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—NRAS—pancreatic cancer	2.7e-06	3.47e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—MYC—pancreatic cancer	2.7e-06	3.47e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—PIK3CD—pancreatic cancer	2.7e-06	3.47e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—STK11—pancreatic cancer	2.7e-06	3.46e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.7e-06	3.46e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—TGFB1—pancreatic cancer	2.69e-06	3.46e-05	CbGpPWpGaD
Ibuprofen—UGT1A3—Metabolism—PIK3CA—pancreatic cancer	2.69e-06	3.45e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—EGFR—pancreatic cancer	2.64e-06	3.39e-05	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—PTEN—pancreatic cancer	2.63e-06	3.38e-05	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—PTEN—pancreatic cancer	2.63e-06	3.38e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—KRAS—pancreatic cancer	2.61e-06	3.35e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—PIK3CG—pancreatic cancer	2.57e-06	3.3e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—TYMS—pancreatic cancer	2.54e-06	3.27e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—PTEN—pancreatic cancer	2.54e-06	3.26e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.53e-06	3.25e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—MYC—pancreatic cancer	2.52e-06	3.23e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—TGFB1—pancreatic cancer	2.51e-06	3.22e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—KRAS—pancreatic cancer	2.49e-06	3.2e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—TYMS—pancreatic cancer	2.48e-06	3.19e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—PIK3CB—pancreatic cancer	2.48e-06	3.19e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—PPARG—pancreatic cancer	2.48e-06	3.19e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—EGFR—pancreatic cancer	2.46e-06	3.16e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—PTGS2—pancreatic cancer	2.46e-06	3.16e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—PIK3CA—pancreatic cancer	2.4e-06	3.08e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—PIK3CB—pancreatic cancer	2.35e-06	3.02e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—KRAS—pancreatic cancer	2.33e-06	2.99e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—TYMS—pancreatic cancer	2.32e-06	2.98e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—TP53—pancreatic cancer	2.32e-06	2.98e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—APOE—pancreatic cancer	2.32e-06	2.98e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—APOE—pancreatic cancer	2.3e-06	2.96e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—PIK3CA—pancreatic cancer	2.29e-06	2.94e-05	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—PIK3CA—pancreatic cancer	2.28e-06	2.93e-05	CbGpPWpGaD
Ibuprofen—PPARG—Gene Expression—AKT1—pancreatic cancer	2.27e-06	2.91e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—PIK3CD—pancreatic cancer	2.26e-06	2.9e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—TP53—pancreatic cancer	2.22e-06	2.85e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—HRAS—pancreatic cancer	2.22e-06	2.85e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.19e-06	2.82e-05	CbGpPWpGaD
Ibuprofen—UGT1A3—Metabolism—AKT1—pancreatic cancer	2.19e-06	2.82e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.18e-06	2.8e-05	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—PIK3CA—pancreatic cancer	2.16e-06	2.77e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—PTEN—pancreatic cancer	2.14e-06	2.75e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—PIK3CA—pancreatic cancer	2.14e-06	2.74e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—HRAS—pancreatic cancer	2.12e-06	2.72e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	2.09e-06	2.69e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—CTNNB1—pancreatic cancer	2.09e-06	2.68e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—PIK3CG—pancreatic cancer	2.08e-06	2.67e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—APOE—pancreatic cancer	2.07e-06	2.66e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—PTEN—pancreatic cancer	2.03e-06	2.61e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—APOE—pancreatic cancer	2.02e-06	2.59e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—PPARG—pancreatic cancer	2.02e-06	2.59e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—PPARG—pancreatic cancer	2.01e-06	2.58e-05	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—PIK3CA—pancreatic cancer	1.99e-06	2.55e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—HRAS—pancreatic cancer	1.98e-06	2.54e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—PIK3CB—pancreatic cancer	1.97e-06	2.53e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.96e-06	2.51e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—AKT1—pancreatic cancer	1.96e-06	2.51e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—APOE—pancreatic cancer	1.89e-06	2.42e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—SRC—pancreatic cancer	1.88e-06	2.42e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—AKT1—pancreatic cancer	1.87e-06	2.4e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	1.87e-06	2.4e-05	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—AKT1—pancreatic cancer	1.87e-06	2.4e-05	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—PIK3CA—pancreatic cancer	1.86e-06	2.38e-05	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—PIK3CA—pancreatic cancer	1.86e-06	2.38e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	1.84e-06	2.36e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—PIK3CD—pancreatic cancer	1.83e-06	2.35e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—PIK3CG—pancreatic cancer	1.82e-06	2.34e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—STAT3—pancreatic cancer	1.82e-06	2.33e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—NRAS—pancreatic cancer	1.81e-06	2.33e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—PPARG—pancreatic cancer	1.8e-06	2.31e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—PIK3CA—pancreatic cancer	1.79e-06	2.3e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.79e-06	2.29e-05	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—AKT1—pancreatic cancer	1.76e-06	2.27e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—PPARG—pancreatic cancer	1.76e-06	2.26e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—AKT1—pancreatic cancer	1.75e-06	2.24e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	1.7e-06	2.19e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—PTEN—pancreatic cancer	1.7e-06	2.19e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—MYC—pancreatic cancer	1.69e-06	2.17e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—TGFB1—pancreatic cancer	1.68e-06	2.16e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—EGFR—pancreatic cancer	1.65e-06	2.12e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—PPARG—pancreatic cancer	1.64e-06	2.11e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	1.64e-06	2.11e-05	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—AKT1—pancreatic cancer	1.62e-06	2.09e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	1.6e-06	2.06e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—PIK3CD—pancreatic cancer	1.6e-06	2.06e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—PIK3CB—pancreatic cancer	1.59e-06	2.05e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—PTGS2—pancreatic cancer	1.59e-06	2.04e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—PTGS2—pancreatic cancer	1.58e-06	2.03e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—KRAS—pancreatic cancer	1.56e-06	2e-05	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—AKT1—pancreatic cancer	1.52e-06	1.95e-05	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—AKT1—pancreatic cancer	1.52e-06	1.95e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—PIK3CA—pancreatic cancer	1.51e-06	1.94e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	1.5e-06	1.92e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—AKT1—pancreatic cancer	1.46e-06	1.88e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—PIK3CA—pancreatic cancer	1.43e-06	1.84e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	1.43e-06	1.84e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—PTGS2—pancreatic cancer	1.42e-06	1.82e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—PIK3CB—pancreatic cancer	1.4e-06	1.79e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—PTEN—pancreatic cancer	1.38e-06	1.78e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—PTGS2—pancreatic cancer	1.38e-06	1.78e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—PTEN—pancreatic cancer	1.38e-06	1.77e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—HRAS—pancreatic cancer	1.33e-06	1.7e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	1.3e-06	1.68e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—PTGS2—pancreatic cancer	1.29e-06	1.66e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—PTEN—pancreatic cancer	1.24e-06	1.59e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—AKT1—pancreatic cancer	1.24e-06	1.59e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—PTEN—pancreatic cancer	1.21e-06	1.55e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—PIK3CA—pancreatic cancer	1.2e-06	1.54e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—AKT1—pancreatic cancer	1.17e-06	1.5e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—PTEN—pancreatic cancer	1.13e-06	1.45e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—AKT1—pancreatic cancer	9.81e-07	1.26e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	9.77e-07	1.25e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—PIK3CA—pancreatic cancer	9.71e-07	1.25e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	8.72e-07	1.12e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—PIK3CA—pancreatic cancer	8.51e-07	1.09e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—AKT1—pancreatic cancer	7.98e-07	1.03e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	7.95e-07	1.02e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—AKT1—pancreatic cancer	7.94e-07	1.02e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—AKT1—pancreatic cancer	7.12e-07	9.15e-06	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—AKT1—pancreatic cancer	6.95e-07	8.93e-06	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—AKT1—pancreatic cancer	6.5e-07	8.34e-06	CbGpPWpGaD
